Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$120.42 - $169.29 $4,816 - $6,771
-40 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$127.18 - $173.91 $7,630 - $10,434
-60 Reduced 60.0%
40 $7,000
Q4 2021

Feb 10, 2022

SELL
$159.56 - $209.29 $7,978 - $10,464
-50 Reduced 33.33%
100 $17,000
Q3 2021

Oct 29, 2021

SELL
$169.75 - $207.73 $10,354 - $12,671
-61 Reduced 28.91%
150 $28,000
Q2 2021

Aug 10, 2021

BUY
$128.63 - $176.89 $1,286 - $1,768
10 Added 4.98%
211 $36,000
Q1 2021

May 11, 2021

SELL
$126.83 - $175.69 $295,006 - $408,654
-2,326 Reduced 92.05%
201 $28,000
Q4 2020

Feb 08, 2021

BUY
$122.97 - $147.0 $310,745 - $371,469
2,527 New
2,527 $328,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Lumature Wealth Partners, LLC Portfolio

Follow Lumature Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lumature Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lumature Wealth Partners, LLC with notifications on news.